EcoDrugPlus

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSMAUG00000015449
Gene Symbol: BCR
3 Cross references
274 Possible Orthologues:

Braf Transforming Gene

Ensembl ID : ENSMAUG00000016066
Gene Symbol: BRAF
1 Cross references
220 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSMAUG00000015410
Gene Symbol: BTK
4 Cross references
206 Possible Orthologues:

C-C Chemokine Receptor Type 1

Ensembl ID : ENSMAUG00000003609
Gene Symbol: LOC101834765
4 Cross references
291 Possible Orthologues:

C-C Chemokine Receptor Type 5

Ensembl ID : ENSMAUG00000000842
Gene Symbol: LOC101833790
4 Cross references
298 Possible Orthologues:

C-C Motif Chemokine Receptor 4

Ensembl ID : ENSMAUG00000010501
Gene Symbol: CCR4
3 Cross references
254 Possible Orthologues:

C-C Motif Chemokine Receptor 9

Ensembl ID : ENSMAUG00000002553
Gene Symbol: CCR9
4 Cross references
262 Possible Orthologues:

C-X-C Motif Chemokine Receptor 2

Ensembl ID : ENSMAUG00000003254
Gene Symbol: CXCR2
4 Cross references
237 Possible Orthologues:

C-X-C Motif Chemokine Receptor 4

Ensembl ID : ENSMAUG00000017285
Gene Symbol: CXCR4
4 Cross references
283 Possible Orthologues:

Dna Methyltransferase 1

Ensembl ID : ENSMAUG00000019579
Gene Symbol: DNMT1
3 Cross references
206 Possible Orthologues:

Dna Topoisomerase I

Ensembl ID : ENSMAUG00000011381
Gene Symbol: TOP1
4 Cross references
270 Possible Orthologues:

Dna Topoisomerase Ii Beta

Ensembl ID : ENSMAUG00000018711
Gene Symbol: TOP2B
4 Cross references
208 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).